Upcoming Events

Learn about our newest partner, HitGen, during a fireside chat featuring Brian Moloney, CBO at HitGen, Sean Brown, VP of Chemistry at Dorian in San Carlos and Guillermo Elias, CEO at Proximity in San Francisco.

About HitGen
HitGen Inc. is a drug discovery research company with headquarters in Chengdu, China, and subsidiaries in Cambridge, UK, and Houston, TX.
HitGen is a world-leader in the development of DNA-Encoded Library (DEL) technology, and its applications to early-stage small molecule drug discovery. With over 1,500 libraries, that collectively comprise more than 1.2 trillion compounds, and with an 80% success rate, HitGen has been collaborating with more than 500 organizations worldwide for over 12 years, facilitated through our diverse and flexible business models. HitGen is also known for its formidable OpenDEL, Custom DEL, and PACfragmentDEL libraries.

In addition, HitGen offers a variety of pre-DEL, post DEL, and stand-alone services, such as protein sciences, H2L/LO/IDD (HitGen has over 200 chemists), DEL-to-PCC, ADME/PK, biophysics, and in vitro and in vivo assays, including a bank of over 100 cell lines.
Other stand-alone services, include fragment-based drug discovery, and structure-based drug design technologies (FBDD/SBDD), as well as emerging technology platforms for nucleic acid synthesis and synthetic therapeutic oligonucleotide (STO), and targeted protein degradation (TPD).

Learn about our newest partner, HitGen, during a fireside chat featuring Brian Moloney, CBO at HitGen, Sean Brown, VP of Chemistry at Dorian in San Carlos and Guillermo Elias, CEO at Proximity in San Francisco.

About HitGen
HitGen Inc. is a drug discovery research company with headquarters in Chengdu, China, and subsidiaries in Cambridge, UK, and Houston, TX.
HitGen is a world-leader in the development of DNA-Encoded Library (DEL) technology, and its applications to early-stage small molecule drug discovery. With over 1,500 libraries, that collectively comprise more than 1.2 trillion compounds, and with an 80% success rate, HitGen has been collaborating with more than 500 organizations worldwide for over 12 years, facilitated through our diverse and flexible business models. HitGen is also known for its formidable OpenDEL, Custom DEL, and PACfragmentDEL libraries.

In addition, HitGen offers a variety of pre-DEL, post DEL, and stand-alone services, such as protein sciences, H2L/LO/IDD (HitGen has over 200 chemists), DEL-to-PCC, ADME/PK, biophysics, and in vitro and in vivo assays, including a bank of over 100 cell lines.
Other stand-alone services, include fragment-based drug discovery, and structure-based drug design technologies (FBDD/SBDD), as well as emerging technology platforms for nucleic acid synthesis and synthetic therapeutic oligonucleotide (STO), and targeted protein degradation (TPD).

Revvity Hours @ 135

Revvity Hours @ 135

April 18 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Hours @ 733

Revvity Hours @ 733

April 18 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Agilent Office Hours @ 930

Agilent Office Hours @ 930

April 24 @ 11:00 am - 1:00 pm

Learn more about our equipment during our bi-monthly office hours.

Founders At Work: Integrated Biosciences

April 24 @ 12:00 pm - 1:00 pm

Targeting age-related diseases with synbio and AI

Integrated Biosciences is an early-stage biotechnology company combining synthetic biology and AI to control cellular stress responses for next-generation therapeutics. The company has pioneered the use of optogenetics, diverse small-molecule chemistry, and ultra-large AI models for drug discovery, identifying new classes of small molecules that are under development for addressing acute, age-related diseases. The company was founded in 2022 by Felix Wong, Ph.D., a leading biophysicist, and Max Wilson, Ph.D., a professor of biology.

Felix Wong, Ph.D.
Co-Founder

Max Wilson, Ph.D.
Co-Founder

Register:

RSVP April 24, 2024
First
Last

Revvity Office Hours @ 953

Revvity Office Hours @ 953

April 25 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Office Hours @ 930

Revvity Office Hours @ 930

April 25 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Eppendorf Office Hours 733

Eppendorf Office Hours 733

April 29 @ 11:00 am - 1:00 pm

Join us for Telesis Bio’s lunch & learn event presented by Thien Dinh (field application scientist), and Felice Butler (business development manager). We will introduce you to Telesis Bio Inc. and the BioXp synthetic and molecular biology workstation located at MBC Biolabs in San Carlos.

Capabilities of the BioXp includes the automated building of mRNA, DNA fragments, clones, amplified DNA and variant libraries from either digital sequences or dsDNA templates, as well as NGS library prep for plasmid/genome sequencing.

We will provide an overview of these capabilities and use cases, and introduce you to some exciting new developments involving stable, easy to use, transfection-ready mRNA synthesized on the BioXp.

Telesis Bio has worked with hundreds of clients over the last several years from emerging start-ups to nearly all Top 25 Biopharma companies in a wide range of synthetic biology applications including Antibody Discovery, mRNA Vaccine Discovery, TCR/CAR, etc.

With the BioXp technology, Telesis Bio has empowered researchers to go from digital sequence to expressed proteins in <10 days (Antibodies, TCRs, CARs, target antigens, engineered proteins etc.), skipping the cloning and transduction steps, allowing them to screen biotherapeutic candidates 75-90% faster and with higher throughput than via outsourcing or traditional benchwork, drastically accelerating their hit-to-lead discovery timelines for blockbuster therapeutics.

Revvity Hours @ 135

Revvity Hours @ 135

May 2 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Hours @ 733

Revvity Hours @ 733

May 2 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Agilent Office Hours @ 930

Agilent Office Hours @ 930

May 8 @ 11:00 am - 1:00 pm

Learn more about our equipment during our bi-monthly office hours.

Revvity Office Hours @ 953

Revvity Office Hours @ 953

May 9 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Office Hours @ 930

Revvity Office Hours @ 930

May 9 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Creating innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.

Our Speakers

Nicholas T. Hertz, Ph.D.
Founder and CEO at Montara Therapeutics

Nicholas T. Hertz, Ph.D., is the Founder and CEO at Montara Therapeutics, a seed stage biotechnology company. At Montara, he is working with an experienced team to create innovative therapies for diseases of the brain with a focus on genetically validated targets to leverage a platform from the Shokat lab that allows CNS specific targeting to enhance drug safety and efficacy. Dr. Hertz completed a B.S. in Biochemistry from UCLA (magna cum laude) and then pursued a Ph.D. in Chemistry and Chemical Biology at UCSF under Dr. Kevan Shokat where they discovered the first class of PINK1 activating molecules and co-founded Mitokinin. Following postdoctoral research in neuroscience with Dr. Marc Tessier-Lavigne at Stanford University he served as CSO of Mitokinin, taking the research from discovery to the clinic. At Mitokinin, Dr. Hertz’s team developed novel small molecule PINK1 activators that could represent the first disease-modifying therapy for Parkinson’s Disease. Mitokinin was acquired in October, 2023.

Dr. Hertz’s has published over 20 publications in leading journals such as Cell, Neuron, and Nature, and he holds more than 12 patents. His work emphasizes the importance of rigorous science, innovative therapeutic development, and the dynamics of collaborative leadership in advancing our understanding and treatment of neurodegenerative diseases.

Kevan M. Shokat, Ph.D.
Investigator of the Howard Hughes Medical Institute,
Professor in the Department of Cellular and Molecular Pharmacology at the UCSF
Professor in the Department of Chemistry at the UC Berkeley

Kevan M. Shokat is currently an Investigator of the Howard Hughes Medical Institute, Professor in the Department of Cellular and Molecular Pharmacology at the University of California at San Francisco and Professor in the Department of Chemistry at the University of California at Berkeley. He received his B.A. in Chemistry from Reed College in 1986, his Ph.D. in organic chemistry at UC Berkeley with Professor Peter Schultz and carried out post-doctoral work in cellular immunology at Stanford University with Professor Chris Goodnow. Kevan’s research group is focused on the discovery of new small molecule tools and drug candidates targeting protein/lipid kinases, GTPases, and RNA helicases. His laboratory utilizes the tools of synthetic organic chemistry, protein engineering, structural biology, biochemistry and cell biology. He was inducted into the National Academy of Sciences (2010), the National Academy of Medicine (2011), and the American Academy of Arts and Sciences (2011). In 2023 he was awarded the Vollum Prize from Reed College, the National Academy of Sciences Award for Scientific Discovery and the Sjöberg Prize from the Royal Swedish Academy of Sciences for ‘discoveries that enable the inhibition of mutated K-Ras in cancer treatment’ and the Heath Memorial Award Lecture, from MD Anderson Cancer Center. In 2024, he was awarded the Edward E. Smissman Award by the ACS Medicinal Chemistry division and also the Hope Funds Award of Excellence for Basic Science. He has commercialized discoveries from his laboratory through co-founding several biotechnology companies including Intellikine, Araxes, Wellspring Biosciences, Kura Oncology, eFFECTOR Therapeutics, Mitokinin, Revolution Medicines, Erasca and Kumquat Biosciences.

Register:

RSVP May 9, 2024
First
Last

Eppendorf Office Hours 930

Eppendorf Office Hours 930

May 13 @ 11:00 am - 1:00 pm

Revvity Hours @ 135

Revvity Hours @ 135

May 16 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Hours @ 733

Revvity Hours @ 733

May 16 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Life Science Vendor’s Showcase

May 22 @ 10:00 am - 2:00 pm

MBC BioLabs Life Science Vendor’s Showcase May 2024

We are excited to host another Life Science Vendor Showcase on May 22nd at our 930 Brittan Avenue, San Carlos location!

The showcase aims to bring together the latest and greatest in life science technologies and services from a variety of vendors. If you are a Life Science vendor and currently not affiliated with MBC, we’d love to have you!

Please register below. The fee to participate is $1,000.

This is an opportunity for our resident scientists and entrepreneurs to explore cutting-edge tools and services, learn about new techniques, resources, and network with other members of the life science community.

2024 Life Science Vendors' Showcase in May

May 2024 Life Science Vendors’ Showcase Application

Please submit your application if you are interested in joining!

Agilent Office Hours @ 930

Agilent Office Hours @ 930

May 22 @ 11:00 am - 1:00 pm

Learn more about our equipment during our bi-monthly office hours.

Revvity Office Hours @ 953

Revvity Office Hours @ 953

May 23 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Revvity Office Hours @ 930

Revvity Office Hours @ 930

May 23 @ 1:00 pm - 3:00 pm

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).

With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.

Eppendorf Office Hours 733

Eppendorf Office Hours 733

May 27 @ 11:00 am - 1:00 pm